Top-News

Grail Aktie News

Aktie
WKN:  A40F8M ISIN:  US3847471014 US-Symbol:  GRAL Land:  USA
101,01 $
-3,695 $
-3,53%
86,760 € 19:53:21 Uhr
Depot/Watchlist
Marktkapitalisierung *
2,47 Mrd. €
Streubesitz
17,25%
KGV
-0,28
Index-Zuordnung
-

Grail News

01.12.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.11.25 - PR Newswire
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference PR Newswire
12.11.25 - PR Newswire
GRAIL Reports Third Quarter 2025 Financial Results
GRAIL Reports Third Quarter 2025 Financial Results PR Newswire
04.11.25 - PR Newswire
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference PR Newswire
29.10.25 - PR Newswire
GRAIL to Announce Third Quarter 2025 Financial Results
GRAIL to Announce Third Quarter 2025 Financial Results PR Newswire
20.10.25 - PR Newswire
GRAIL, Inc. Announces $325.0 Million Private Placement Financing
GRAIL, Inc. Announces $325.0 Million Private Placement Financing PR Newswire
20.10.25 - PR Newswire
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-​Cancer Early Detection Test in Symptomatic Individuals at the ...
17.10.25 - PR Newswire
/U P D A T E -- GRAIL, Inc./
/U P D A T E -- GRAIL, Inc./ PR Newswire
17.10.25 - PR Newswire
Precision Oncology Approaches Drive $312B Market Transformation
Precision Oncology Approaches Drive $312B Market Transformation PR Newswire
17.10.25 - PR Newswire
Precision Oncology Approaches Drive $312B Market Transformation
Precision Oncology Approaches Drive $312B Market Transformation PR Newswire
16.10.25 - PR Newswire
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-​Cancer Early Detection Test to Asia PR Newswire
23.09.25 - PR Newswire
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC PR ...
10.09.25 - PR Newswire
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum PR Newswire
29.08.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
26.08.25 - PR Newswire
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire
12.08.25 - PR Newswire
GRAIL Reports Second Quarter 2025 Financial Results
GRAIL Reports Second Quarter 2025 Financial Results PR Newswire
30.07.25 - PR Newswire
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference PR Newswire
29.07.25 - PR Newswire
GRAIL to Announce Second Quarter 2025 Financial Results
GRAIL to Announce Second Quarter 2025 Financial Results PR Newswire
20.06.25 - PR Newswire
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology PR Newswire
20.06.25 - PR Newswire
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »